 |
| Attached files |
| File | Filename |
| EX-23 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Biota Pharmaceuticals, Inc. | d262743dex23.htm |
| 10-K - FORM 10-K - Biota Pharmaceuticals, Inc. | d262743d10k.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R20.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R10.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R5.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R21.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R16.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R14.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R13.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R15.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R19.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R23.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R11.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R12.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R4.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R18.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R1.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R17.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R7.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R24.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R22.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R6.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R2.htm |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R8.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - Biota Pharmaceuticals, Inc. | R9.htm |
| EX-32 - SECTION 1350 CERTIFICATION - Biota Pharmaceuticals, Inc. | d262743dex32.htm |
| EX-31.1 - RULE 13A-14(A)/15D-14(A) CERTIFICATION - Biota Pharmaceuticals, Inc. | d262743dex311.htm |
v2.4.0.6
|
Consolidated Balance Sheets (Parenthetical) (USD $)
|
Dec. 31, 2011
|
Dec. 25, 2010
|
| Common stock, par value |
$ 0.10 |
$ 0.10 |
| Common stock, shares authorized |
125,000,000 |
125,000,000 |
| Common stock, shares issued |
63,588,882 |
63,206,393 |
| Treasury stock, shares |
20,696,277 |
20,696,277 |
|
Convertible Preferred Stock [Member]
|
|
|
| Convertible preferred stock, par value |
$ 0.10 |
$ 0.10 |
| Convertible preferred stock, shares authorized |
5,000,000 |
5,000,000 |
| Convertible preferred stock, shares outstanding |
0 |
0 |
| X |
- Definition
Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
num:perShareItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_CommonStockSharesAuthorized |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_CommonStockSharesIssued |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 02
-Paragraph 29
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
+ Details
| Name: |
us-gaap_PreferredStockParOrStatedValuePerShare |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
num:perShareItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 02
-Paragraph 29
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_PreferredStockSharesAuthorized |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 02
-Paragraph 29
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_PreferredStockSharesOutstanding |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
| X |
- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details
| Name: |
us-gaap_TreasuryStockShares |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:sharesItemType |
| Balance Type: |
na |
| Period Type: |
instant |
|
This web site and associated pages are not associated with, endorsed by, or sponsored by Biota Pharmaceuticals, Inc. and has no official or unofficial affiliation with Biota Pharmaceuticals, Inc.
Based on public records. Inadvertent errors are possible. Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
|
|